Enloe Medical Center Infusion is categorized under Medical Centers in Chico, CA and active since 2010.
Enloe Medical Center Infusion was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6221100 by the NAICS.
If you are seeking more information, feel free to contact Nancy Ladoyon, Manager at the company’s single location by writing to 265 Cohasset Road, Chico, California CA 95926 or by phoning (530) 332-3917. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Enloe Medical Center Infusion |
Contact Person: | Nancy Ladoyon, Manager |
Address: | 265 Cohasset Road, Chico, California 95926 |
Phone Number: | (530) 332-3917 |
Website Address: | enloe.org |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Centers |
SIC Code: | 8011 |
NAICS Code: | 6221100 |
Share This Business: |
Enloe Medical Center Infusion was started in 2010 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6221100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Nancy Ladoyon, Manager for inquiries that concern Enloe Medical Center Infusion by calling the company number (530) 332-3917, as your correspondence is most welcome. Additionally, the physical location of the single location of Enloe Medical Center Infusion can be found at the coordinates 39.75169,-121.85181 as well as the street address 265 Cohasset Road in Chico, California 95926.
For its online presence, you may visit Enloe Medical Center Infusion’s website at enloe.org and engage with its social media outlets through on Twitter and on Facebook.